Description:

ODM derived from http://clinicaltrials.gov/show/NCT00717457

Link:

http://clinicaltrials.gov/show/NCT00717457

Keywords:
Versions (2) ▾
  1. 12/9/13
  2. 4/16/14
Uploaded on:

April 16, 2014

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00717457 Diabetes Mellitus, Type 2

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
age 18 Years to 75 Years
Adult (person)
type 2 diabetes receiving metformin and/or pioglitazone or rosiglitazone for at least 12 weeks
HbA1c >=7.0% and <=10% at screening
BMI >=25kg/m2 (>23kg/m2 for Asians) and <=45kg/m2 at screening
stable weight +/- 5% for at least 12 weeks prior to screening.
Exclusion Criteria
history of type 1 diabetes, diabetes resulting from pancreatic injury or secondary forms of diabetes
history of acute metabolic diabetic complications within the previous 6 months
evidence of clinically significant diabetic complications
Proliferative diabetic retinopathy
myocardial infarction (MI), coronary artery bypass surgery, post-transplantation cardiomyopathy (PTCM) or stroke within the past 6 months
any abnormality in clinical laboratory test or ECG, which precludes safe involvement in the study as judged by the investigator
known hemoglobinopathy or chronic anemia
clinically significant gastrointestinal disease.

Similar models